US 12201593
Oral pharmaceutical formulations of bitter compounds for asthma
granted A61KA61K31/136A61K31/167
Quick answer
US patent 12201593 (Oral pharmaceutical formulations of bitter compounds for asthma) held by Aardvark Therapeutics, Inc. expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aardvark Therapeutics, Inc.
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/136, A61K31/167, A61K9/0053, A61K9/48